Central nervous system control of intraocular pressure

Summary— Normal intraocular pressure (IOP) is the result of an equilibrium between aqueous humor (AH) production, AH outflow and episcleral venous pressure. Most available antiglaucoma agents produce their effects by interacting with autonomic mechanisms (beta‐blockers, epinephrin or parasympathomimetics). In contrast, the role of the central nervous system (brain and nerves) in the regulation of IOP remains unclear in view of the complex haemodynamic, metabolic or hormonal changes which occur under experimental conditions. In this paper, we discuss a basic understanding of the anatomic and physiological relationships between central nervous system and IOP and describe how the brain can affect functions in ciliary body and trabeculum meshwork.

[1]  A. Bill.  Effects of some neuropeptides on the uvea , 1991 .

[2]  G. Chiou,et al.  Effect of permeation enhancers on beta-endorphin systemic uptake after topical application to the eye. , 1991, Ophthalmic research.

[3]  J. Nordmann,et al.  Localization and characterization of substance P binding sites in rat and rabbit eyes. , 1991, Investigative ophthalmology & visual science.

[4]  J. Nordmann,et al.  Autoradiographic characterization and localization of vasoactive intestinal peptide binding sites in albino rat and rabbit eyes. , 1991, Experimental eye research.

[5]  J. H. Liu,et al.  Thyrotropin releasing hormone increases intraocular pressure. Mechanism of action. , 1989, Investigative ophthalmology & visual science.

[6]  R. Stone,et al.  The ocular hypotensive effects of demeclocycline, tetracycline and other tetracycline derivatives. , 1989, Investigative ophthalmology & visual science.

[7]  J. Meijer,et al.  Neurophysiology of the suprachiasmatic circadian pacemaker in rodents. , 1989, Physiological reviews.

[8]  K. Krootila.  CGRP in relation to neurogenic inflammation and cAMP in the rabbit eye. , 1988, Experimental eye research.

[9]  G. Chiou,et al.  Systemic delivery of polypeptides with molecular weights of between 300 and 3500 through the eyes. , 1988, Journal of ocular pharmacology.

[10]  V. Lee.  Enzymatic barriers to peptide and protein absorption. , 1988, Critical reviews in therapeutic drug carrier systems.

[11]  J. M. Butler,et al.  Neuropeptides in the uveal tract , 1988, Eye.

[12]  R. Stone,et al.  Distinct substance P and calcitonin gene-related peptide immunoreactive nerves in the guinea pig eye. , 1987, Investigative ophthalmology & visual science.

[13]  S. Podos,et al.  Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes. , 1987, The Journal of pharmacology and experimental therapeutics.

[14]  J. Trzeciakowski.  Central control of intraocular pressure. , 1987, Journal of ocular pharmacology.

[15]  T. Krupin,et al.  Central effects of vasoactive intestinal polypeptide on intraocular pressure and body temperature in rabbits. , 1987, Current eye research.

[16]  J. Trzeciakowski,et al.  Effects of intraventricular histamine and H2 receptor antagonists on intraocular pressure. , 1987, Journal of ocular pharmacology.

[17]  C. Wahlestedt,et al.  Calcitonin gene-related peptide in the eye: release by sensory nerve stimulation and effects associated with neurogenic inflammation , 1986, Regulatory Peptides.

[18]  A. Tarkkanen,et al.  Vasoactive intestinal polypeptide‐like immunoreactive nerves to the human eye , 1986, Acta ophthalmologica.

[19]  R. Stratford,et al.  Metabolic and permeation barriers to the ocular absorption of topically applied enkephalins in albino rabbits. , 1986, Journal of ocular pharmacology.

[20]  F. Drago,et al.  EFFECTS OF OPIATES AND OPIOIDS ON INTRAOCULAR PRESSURE OF RABBITS AND HUMANS , 1985, Clinical and experimental pharmacology & physiology.

[21]  J. H. Liu,et al.  Study of central regulation of intraocular pressure using ventriculocisternal perfusion. , 1985, Investigative ophthalmology & visual science.

[22]  J. M. Butler,et al.  Calcitonin gene-related polypeptide as a mediator of the neurogenic ocular injury response. , 1985, Journal of ocular pharmacology.

[23]  W. Unger,et al.  The response of the isolated iris sphincter muscle of various mammalian species to substance P. , 1984, Experimental Eye Research.

[24]  A. Laties,et al.  Neuron-specific enolase-containing cells in the rhesus monkey trabecular meshwork. , 1984, Investigative ophthalmology & visual science.

[25]  T. Krupin,et al.  Central effects of thyrotropin-releasing hormone and arginine vasopressin on intraocular pressure in rabbits. , 1984, Investigative ophthalmology & visual science.

[26]  S. Nilsson,et al.  Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows. , 1984, Acta physiologica Scandinavica.

[27]  A. Bill,et al.  Regional cerebral, ocular and peripheral vascular effects of naloxone and morphine in unanesthetized rabbits. , 1983, Acta physiologica Scandinavica.

[28]  F. Sundler,et al.  A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. , 1981, Science.

[29]  Y. Shoenfeld,et al.  The relationship between body temperature and intraocular pressure. , 1981, Annals of ophthalmology.

[30]  A. Bill,et al.  Substance P: release on trigeminal nerve stimulation, effects in the eye. , 1979, Acta physiologica Scandinavica.

[31]  R. Brubaker,et al.  Intraocular pressure after optic nerve transection. , 1978, Investigative ophthalmology & visual science.

[32]  S. Nagasubramanian.  Role of pituitary vasopressin in the formation and dynamics of aqueous humour. , 1977, Transactions of the ophthalmological societies of the United Kingdom.

[33]  T. Krupin,et al.  Increased intraocular pressure after third ventricle injections of prostaglandin E1 and arachidonic acid. , 1976, American journal of ophthalmology.

[34]  F. Vrabec.  Encapsulated sensory corpuscles in the sclerocorneal boundary tissues of the killer whale Orcinus orca L. , 1972, Acta anatomica.

[35]  C. Belmonte,et al.  Effects of intraocular pressure changes on the afferent activity of ciliary nerves. , 1971, Experimental eye research.

[36]  T. Krupin,et al.  Mechanism of intraocular pressure response after optic nerve transection. , 1971, American journal of ophthalmology.

[37]  R. Lehman,et al.  Effects of optic nerve transection on intraocular pressure in monkeys. , 1970, Archives of ophthalmology.

[38]  S. E. Simonsen,et al.  INTRAOCULAR PRESSURE IN UNILATERAL OPTIC NERVE LESION , 1969, Acta ophthalmologica.

[39]  J. Gloster,et al.  INFLUENCE OF THE FACIAL NERVE ON INTRA-OCULAR PRESSURE* , 1961, The British journal of ophthalmology.

[40]  J. Gloster.  RESPONSES OF THE INTRA-OCULAR PRESSURE TO DIENCEPHALIC STIMULATION* , 1960, The British journal of ophthalmology.

[41]  J. Gloster,et al.  EFFECT OF DIENCEPHALIC STIMULATION UPON INTRA-OCULAR PRESSURE* , 1957, The British journal of ophthalmology.

[42]  E. Perkins.  INFLUENCE OF THE FIFTH CRANIAL NERVE ON THE INTRA-OCULAR PRESSURE OF THE RABBIT EYE*† , 1957, British Journal of Ophthalmology.

[43]  O. Lowenstein,et al.  Responses of intraocular pressure, blood pressure, and cutaneous vessels to electric stimulation in the diencephalon: the ninth Francis I. Proctor Lecture. , 1955, American journal of ophthalmology.